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Fever-Induced Paroxysmal Weakness and Encephalopathy
(FIPWE)—Part of a Phenotypic Continuum in Patients With
ATP1A3 Mutations?
We read with interest the article by Yano et al,1 identifying
a new phenotype of patients with a heterozygous muta-
tion in the gene encoding the sodium-potassium ATPase
alpha-3 subunit (ATP1A3) at c.2267G>A (residue 756). Pre-
viously, speciﬁc ATP1A3 genemutations were associated with
unique phenotypes, including alternating hemiplegia of child-
hood (AHC), rapid-onset dystonia-parkinsonism (RDP/
DYT12), and cerebellar ataxia, pes cavus, optic atrophy,
sensorineural hearing loss.2 In children with ATP1A3 gene
mutations, Yano et al. described a group of patients with
another phenotype, presenting with fever-induced parox-
ysmal muscle weakness and encephalopathy (FIPWE). The
authors allocate this speciﬁc clinical presentation to a mu-
tation at a single residue 756 (p.(Arg756Leu), p.(Arg756His),
or p.(Arg756Cys)).1
In addition to recognition of separate genotype-phenotype
relationships, awareness of the phenotypic continuum of
ATP1A3 mutations is necessary.3 This is illustrated by three
of our patients with FIPWE-like features, who were re-
ported with different de novo ATP1A3 gene mutations. The
ﬁrst two (unrelated) children were both diagnosed with an
identical de novo ATP1A3 gene mutation at c.2266C>T,
p.(Arg756Cys) (NM_152296.4). These two children suf-
fered from fever-induced attacks with paroxysmal muscle
weakness, encephalopathy, ataxia, chorea, dystonia, and
mutism. The third child was diagnosedwith a de novo ATP1A3
genemutation at c. 2232C>A, p.(Asn744Lys) (NM_152296.4).
He suffered from three severe fever- and stress-induced
attacks with paroxysmal muscle weakness, asymmetrical
dystonia, mutism, electroencephalographic seizure activi-
ty, and encephalopathy. All three children recovered in
between attacks, albeit incomplete and slowly. In the ﬁrst
two children, the FIPWE phenotype-genotype relationship
was established. The symptoms of the third patient, however,
were attributed to a spectrum of overlapping acronyms (AHC,
RPD, and FIPWE).
Although genetically different, these three patients with
ATP1A3-related disorders may illustrate that the symp-
toms associated with the FIPWE phenotype1,4 are
encompassed within a broader phenotypic continuum of
ATP1A3 gene mutations. Assigning overly exact phenotype-
genotype relationships could promote inaccurate
interpretation of the overlapping phenotypes within the
broad phenotypic spectrum of ATP1A3-related disorders. Fur-
thermore, clinicians need to be aware that laboratories may
report speciﬁc mutations differently, and therefore we advise
that publications on the association between a new acronym
and a speciﬁc gene mutation also mention the reference se-
quence accession number (NM_number). This could alert
clinicians that their previous patients with similar pheno-
types could have been reported differently by another genetic
reference sequencing, in the past.
Until now, it remains unclear whether, and if so, which
molecular mechanisms underlie these disease presenta-
tions. In patients with ATP1A3 gene mutations, we hope that
future insight in the spectrum of genotype-phenotype re-
lationships will add to our understanding of the pathogenesis
and to potential therapeutic strategies to prevent these dev-
astating attacks.
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